SCHEMBL1900378

SCHEMBL1900378

O=C(O)CN1C(=O)C(=Cc2cn(-c3ccc(Cl)cc3)nc2-c2ccc(Cl)cc2)SC1=S

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.80
MEN1 O00255 3/20 0.80
POLB P06746 2/20 0.80
PTPN1 P18031 12/20 0.77
MAPT P10636 2/20 0.77
PKM P14618 2/20 0.77
MCL1 Q07820 2/20 0.77
NPSR1 Q6W5P4 2/20 0.77
MAPK1 P28482 1/20 0.77
GALK1 P51570 1/20 0.77
PTPN2 P17706 1/20 0.71
PTPN6 P29350 1/20 0.71
CDC25B P30305 1/20 0.71
PTPN11 Q06124 1/20 0.71
HIF1AN Q9NWT6 1/20 0.71
PTGES O14684 2/20 0.70
DUSP3 P51452 1/20 0.69
BLM P54132 2/20 0.68
DNMT1 P26358 2/20 0.68
PLEC Q15149 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1900374 1.00 KMT2A (0.80) KMT2AMEN1POLBPTPN1MAPT
SCHEMBL1900377 1.00 KMT2A (0.80) KMT2AMEN1POLBPTPN1MAPT
SCHEMBL1904142 0.90 PTPN1 (0.93) KMT2AMEN1POLBPTPN1MAPT
SCHEMBL3178417 0.90 PTPN1 (0.93) KMT2AMEN1POLBPTPN1MAPT
SCHEMBL1904141 0.90 PTPN1 (0.93) KMT2AMEN1POLBPTPN1MAPT
SCHEMBL1905824 0.90 KMT2A (0.80) KMT2AMEN1POLBPTPN1MAPT
SCHEMBL3186009 0.90 KMT2A (0.80) KMT2AMEN1POLBPTPN1MAPT
SCHEMBL1905826 0.90 KMT2A (0.80) KMT2AMEN1POLBPTPN1MAPT
SCHEMBL1904875 0.89 KMT2A (1.00) KMT2AMEN1POLBPTPN1MAPT
SCHEMBL1904877 0.89 KMT2A (1.00) KMT2AMEN1POLBPTPN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7947717-B2 Inhibitors of lethal factor protease BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2011-05-24 US disclosed
US-20100016292-A1 INHIBITORS OF LETHAL FACTOR PROTEASE THE BURNHAM INSTITUTE (US) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016292-A1 INHIBITORS OF LETHAL FACTOR PROTEASE APAF1, F11, SERPINB1 KMT2A 3345/4885MEN1 1839/4885POLB 3712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.